Veravas
Veravas is a leading innovator in clinical diagnostics focused on early detection and prognostic screening for Alzheimer's disease and other neurological conditions. The company's proprietary VeraBIND™ technology transforms challenging sample types into measurable biomarkers, enabling earlier disease detection and the development of novel diagnostic tests. Its VeraBIND Tau assay is a first-in-class blood-based test that measures the pathological activity of hyperphosphorylated tau in blood samples of cognitively normal individuals or individuals experiencing cognitive impairment which may be used to aid in the diagnosis of Alzheimer's disease.
Content by Veravas
|2 min read
First Blood Test to Detect Alzheimer's-Related Tau Pathology
VeraBIND™ Tau is a new noninvasive test that offers 96 percent sensitivity and 90 percent specificity, empowering earlier and more accessible Alzheimer's detectionPage 1 of 1
